Medical
Biotechnology
Biopharmaceutical

Amgen

$188.40
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.68 (0.90%) Today
+$0.13 (0.07%) After Hours

Why Robinhood?

You can buy or sell Amgen and other stocks, options, ETFs, and crypto commission-free!

About

Amgen Inc. Common Stock, also called Amgen, is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Read More Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Employees
21,500
Headquarters
Thousand Oaks, California
Founded
1980
Market Cap
117.48B
Price-Earnings Ratio
14.93
Dividend Yield
2.71
Average Volume
2.96M
High Today
$189.59
Low Today
$187.03
Open Price
$187.55
Volume
1.15M
52 Week High
$210.19
52 Week Low
$163.31

Collections

Medical
Biotechnology
Biopharmaceutical
Health
Cancer Prevention
Pharmaceutical
Therapy
Manufacturing

News

Yahoo Finance4h

Top Research Reports for Apple, Amgen & United Technologies

Tuesday, March 26, 2019 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Amgen (AMGN) and United Technologies (UTX). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. You can see all of today’s research reports here >>> Apple’s shares have gained +9.2% in the past year and have outperformed the broader market with the S...

6
Yahoo Finance7h

Were Hedge Funds Right About Amgen, Inc. (AMGN)?

Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don't make them change their opinion towards a company.

19
PR Newswire9h

Verantos Announces Collaboration with Amgen on Real World Evidence

PALO ALTO, Calif., March 26, 2019 /PRNewswire/ -- Verantos, the market leader in regulatory-grade electronic health record (EHR)-based studies, today announced a collaboration with Amgen focused on the use of advanced data sources and artificial intelligence (AI) to achieve high-accuracy observational studies. The collaboration is focused on how current real-world evidence (RWE) techniques in cardiovascular medicine may be advanced with natural language processing and machine learning to achieve more timel...

4

Earnings

$2.89
$3.20
$3.52
$3.83
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Available Apr 30, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.